Pfizer's Aricept Puts TBWA\C\D on Notice

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

NEW YORK Pfizer has placed Omnicom Group’s TBWA\Chiat\Day on 90-day notice for the drugmaker’s Aricept brand, which the New York shop has handled since 1996, sources said. Billings on the account, which encompasses direct-to-consumer creative duties, are estimated at $20 million.

Sources expect Pfizer to launch a review of the business. TBWA\C\D declined comment and the New York client could not immediately be reached.

All told, Pfizer last year spent about $55 million in major media on the brand, according to Nielsen Monitor-Plus.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in